{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-123356","form_type":"8-K","ticker":"DH","cik":"0001861795","company_name":"Definitive Healthcare Corp.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.149191+00:00","generated_at":"2026-05-30T03:54:01.285428+00:00","sec_items":["2.02","5.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Definitive Healthcare Q3 revenue beats at $62.7M; CFO Booth to depart June 2025; $100M buyback authorized","bullets":["Q3 revenue $62.7M, down 4% YoY; net loss $(187.8)M includes $228.2M goodwill impairment; adjusted EBITDA $20.6M (33% margin).","CFO Richard Booth to leave effective June 1, 2025; granted 92,379 RSUs as retention incentive; search for successor underway.","Board authorized $100M stock repurchase program expiring Dec 31, 2025; replaces prior $20M program; no repurchases yet.","Entered voting agreement with Advent International to limit excess voting shares above 40.3% proportionally.","Guidance: Q4 revenue $60-61M, adjusted EBITDA $16-17M; full-year revenue $250-251M, adjusted EBITDA $77.5-78.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-123356","json":"https://secwatch.observer/filing/0000950170-24-123356.json","markdown":"https://secwatch.observer/filing/0000950170-24-123356.md","text":"https://secwatch.observer/filing/0000950170-24-123356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024123356/0000950170-24-123356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024123356/dh-20241101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:54:01.285428+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b9aef3354","claim":"Richard Booth departed as Chief Financial Officer at Definitive Healthcare Corp..","evidence_excerpt":"Richard Booth, the Company’s Chief Financial Officer, and the Company agreed that Mr. Booth will be leaving the Company effective June 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1861795/000095017024123356/0000950170-24-123356-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"agreed to leave"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}